Live and recent posts from across the Fediverse tagged #biotechnews, aggregated by home.social.
Institutional Mismatch: The Fragility of Biotech Governance
FDA leadership changes cause delays and confusion for new biotech drug approvals. Scientists and investors are affected by the lack of clear rules.
#FDADelays, #BiotechNews, #DrugApproval, #USPolitics, #HealthcareUpdate
https://newsletter.tf/fda-leadership-loss-biotech-drug-approvals-2026/
New FDA rules are causing confusion for biotech companies. This is different from last year when approvals were faster.
#FDADelays, #BiotechNews, #DrugApproval, #USPolitics, #HealthcareUpdate
https://newsletter.tf/fda-leadership-loss-biotech-drug-approvals-2026/
China is no longer just a biotech market. It is increasingly a source of licensable innovation for global pharma.
Sanofi’s up-to-$1.53B rovadicitinib deal is the latest signal — and part of a much bigger shift in where drug innovation begins.
https://biotech.industryexaminer.com/sanofi-china-biotech-licensing-global-innovation/
#Biotech #Pharma #ChinaBiotech #DrugDevelopment #BiotechNews #TechNews
FDA lifted the clinical hold on Intellia’s MAGNITUDE Phase 3 (ATTR-CM). The headline says “resume.”
The real story: a safety reset—tighter selection + heavier liver monitoring + explicit mitigation steps.
Our take: “conditional confidence” is the new normal for one-and-done biology.
https://biotech.industryexaminer.com/crispr-safety-reset-intellia-fda-hold-lift/
CAR-T works. But it’s bespoke: collect cells, engineer, ship back — often 3–6 weeks. Lilly’s up-to-$2.4bn Orna deal bets on in-vivo CAR-T (circular RNA + LNPs) to make an autoimmune “immune reset” scalable. https://biotech.industryexaminer.com/lilly-orna-in-vivo-car-t-circular-rna-autoimmune/
#Biotech #CART #EliLilly #TechNews #BiotechNews
FDA clears oral Wegovy (daily semaglutide) for chronic weight management — and CV risk reduction in adults with CVD. In OASIS 4: 16.6% mean weight loss vs 2.7% placebo (64 wks). Convenience is real; coverage decides scale.
https://biotech.industryexaminer.com/fda-approves-oral-glp-1-wegovy-pill-semaglutide-obesity/
#GLP1 #Biotech #Obesity #Pharma #TechNews #BiotechNews
Biotechs are moving beyond cow-free dairy into Human Milk 2.0 – brewing breast milk proteins like lactoferrin in steel tanks for the US$90bn formula market. Science, economics, ethics all collide in our new explainer 👇
https://biotech.industryexaminer.com/cow-free-dairy-human-milk-breast-milk-proteins/
#Biotech #AlternativeDairy #HumanMilk2_0 #BiotechNews #TechNews #foodtech #precisionfermentation #infantnutrition
🚀🎉 Breaking news: removing newlines from your genome sequences makes them magically compress better! Who knew that deleting a single character could turn you into the Einstein of file compression? 🤯 Just another day in the life of a cutting-edge digital genius. 🙄
https://log.bede.im/2025/09/12/zstandard-long-range-genomes.html #genomecompression #digitalinnovation #filecompression #biotechnews #cuttingedge #HackerNews #ngated